Cary, NC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Hidradenitis Suppurativa Foundation Inc, founded in 2005, is a community nonprofit that reported $1.2M in total revenue in fiscal year 2022. Revenue surged 74% from the prior year, signaling strong growth momentum. Expenses of $1.1M left a modest 3% surplus.
THE MISSION OF THE HS FOUNDATION IS TO IMPROVE THE LIVES OF PEOPLE AFFECTED BY HS THROUGH ADVOCACY, EDUCATION AND RESEARCH.
THE SEVENTH ANNUAL SYMPOSIUM ON HIDRADENITIS SUPPURATIVA ADVANCES (SHSA) WAS HELD OCTOBER 7-9, 2022, IN MIAMI, FLORIDA. CO-ORGANIZEDWITH THE CANADIAN HS FOUNDATION, OVER 250 REGISTRANTS FROM...
THE SEVENTH ANNUAL SYMPOSIUM ON HIDRADENITIS SUPPURATIVA ADVANCES (SHSA) WAS HELD OCTOBER 7-9, 2022, IN MIAMI, FLORIDA. CO-ORGANIZEDWITH THE CANADIAN HS FOUNDATION, OVER 250 REGISTRANTS FROM SEVENCOUNTRIES ATTENDED THE EVENT, INCLUDING OVER 30 PATIENTS ANDCAREGIVERS AND OVER 175 RESEARCHERS AND MEDICAL PROVIDERS. THE LATEST ADVANCEMENTS IN HS TREATMENT AND RESEARCH WERE PRESENTED.
AS PART OF THE TRANSLATIONAL GRANT PROGRAM, HS FOUNDATION AWARDED $95,000, WHICH CONSISTED OF $75,000 FOR HS PROGRESS AND $20,000 FOR SITE ONBOARDING. THIS FUNDING REPRESENTED THE FINAL YEAR OF SEED...
AS PART OF THE TRANSLATIONAL GRANT PROGRAM, HS FOUNDATION AWARDED $95,000, WHICH CONSISTED OF $75,000 FOR HS PROGRESS AND $20,000 FOR SITE ONBOARDING. THIS FUNDING REPRESENTED THE FINAL YEAR OF SEED FUNDING FOR THE PROGRAM, AS WELL AS FUNDS FOR THE ONBOARDING OF TWO ADDITIONAL SITES.
THE HS FOUNDATION HELD ITS SECOND ANNUAL EDUCATIONAL EVENT TARGETEDTOWARDS DERMATOLOGY RESIDENTS. THE PURPOSE OF THE EVENT, KNOWN AS HS ACADEMY, WAS TO EDUCATE THE NEXT GENERATION OF DERMATOLOGISTS...
THE HS FOUNDATION HELD ITS SECOND ANNUAL EDUCATIONAL EVENT TARGETEDTOWARDS DERMATOLOGY RESIDENTS. THE PURPOSE OF THE EVENT, KNOWN AS HS ACADEMY, WAS TO EDUCATE THE NEXT GENERATION OF DERMATOLOGISTS ABOUT THE LATEST ADVANCEMENTS IN DIAGNOSIS, PATHOGENESIS, EPIDEMIOLOGY AND COMORBIDITIES, AS WELL AS MEDICAL AND PROCEDURE-BASED TREATMENTS FOR HIDRADENITIS SUPPURATIVA THROUGH LECTURE, BREAK-OUT SESSIONS, AND CASE-BASED STUDIES WITH RENOWNED EXPERTS AND PATIENTS. OVER 110 RESIDENTS ATTENDED THIS TWO-DAY EDUCATIONAL EXPERIENCE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $1,179,185 | $679,044 | +0.7% |
| Expenses | $1,139,182 | $386,599 | +1.9% |
| Net Income | $40,003 | $292,445 | -0.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ILTEFAT HAMZAVI MD | IMMEDIATE PAST PRESIDENT | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSLYN R SCIACCA KIRBY MD | PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| HADAR LEV-TOV MD | VICE PRESIDENT | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARTIN OKUN MD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ATHENA GIERBOLINI | DIRECTOR | 1.00 |
Director
|
$2,500 | $0 | $2,500 |
| JENNIFER HSIAO MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTOPHER SAYED MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HALEY NAIK MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHELLE LOWES MBBS PHD | DIRECTOR | 1.00 |
Director
|
$2,500 | $0 | $2,500 |
| AMIT GARG MD | DIRECTOR | 1.00 |
Director
|
$3,500 | $0 | $3,500 |
| BARRY RESNIK MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHANIE GOLDBERG MD | DIRECTOR | 1.00 |
Director
|
$2,500 | $0 | $2,500 |
| VIVIAN SHI MD | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| STEVEN DAVELUY MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| AFSANEH ALAVI MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DONNA ATHERTON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GINETTE OKOYE MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRENT HAZELETT | EXECUTIVE DIRECTOR | 45.00 |
Officer
|
$225,000 | $0 | $225,000 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2022 | $1,179,185 | $1,139,182 | No data | $40,003 |
| 2021 | $679,044 | $386,599 | $1,219,380 | $292,445 |
| 2020 | $444,806 | $241,359 | $842,509 | $203,447 |
| 2019 | $460,786 | $307,368 | $645,685 | $153,418 |
Compare Hidradenitis Suppurativa Foundation Inc with other nonprofits in North Carolina and across the country.